Senate
File
2119
H-8137
Amend
the
amendment,
H-8118,
to
Senate
File
2119,
as
passed
1
by
the
Senate,
as
follows:
2
1.
Page
1,
after
line
7
by
inserting:
3
<
Sec.
___.
NEW
SECTION
.
124.101C
Injection
drug
use
——
4
legislative
findings.
5
The
general
assembly
of
the
state
of
Iowa
finds
and
declares
6
the
following:
7
1.
Injection
drug
use
is
the
main
driver
for
increases
in
8
hepatitis
C
cases
among
young
adults
due
partially
to
recent
9
increases
in
the
misuse
of
prescription
and
nonprescription
10
opioids
as
well
as
increases
in
opioid
injections.
11
2.
The
number
of
patients
diagnosed
with
opioid
use
disorder
12
increased
three
hundred
seventy-eight
percent
from
thirty-nine
13
thousand
one
hundred
nine
in
1999
to
one
hundred
eighty-six
14
thousand
nine
hundred
seventy-nine
in
2013
in
a
seventeen-state
15
sample.
16
3.
Opioid
use
disorder
imposes
considerable
financial
17
burdens
on
state
Medicaid
programs,
and
the
burden
is
18
increasing
over
time.
After
adjusting
for
inflation,
total
19
Medicaid
costs
associated
with
opioid
use
disorder
more
than
20
tripled
over
a
five-year
time
period,
reaching
more
than
21
three
billion
dollars
in
2013,
from
nine
hundred
nineteen
22
million
dollars
in
1999,
with
most
of
the
growth
due
to
excess
23
nonopioid
use
disorder
treatment
costs
for
patients
with
opioid
24
use
disorder,
which
increased
three
hundred
sixty-three
percent
25
over
the
period,
triple
the
rate
of
growth
in
expenditures
for
26
opioid
use
disorder
treatment
services.
27
4.
Findings
extrapolated
to
the
entire
United
States
28
suggest
that
the
Medicaid
costs
associated
with
opioid
use
29
disorder
increased
from
more
than
two
billion
dollars
in
1999
30
to
more
than
eight
billion
dollars
in
2013,
with
the
cumulative
31
costs
over
a
fifteen-year
time
period
amounting
to
more
than
32
seventy-two
billion
four
hundred
million
dollars.
33
5.
The
centers
for
disease
control
and
prevention
of
34
the
United
States
department
of
health
and
human
services
35
-1-
H8118.3694
(3)
88
ss/rh
1/
2
#1.
recommends
that
states
scale
up
effective
programs
to
promote
1
drug
treatment
as
well
as
hepatitis
testing
and
treatment
2
efforts
in
local
communities.
3
6.
Syringe
services
can
be
important
in
reducing
the
risk
4
of
infection
with
blood-borne
pathogens
such
as
hepatitis
5
B
and
HIV,
as
well
as
hepatitis
C,
and
should
be
part
of
a
6
comprehensive
program
that
also
addresses
access
to
treatment,
7
medication-assisted
treatment,
and
education
of
medical
8
professionals
on
the
appropriate
prescription
of
opioids.
9
7.
Syringe
services
programs
are
a
proven
method
of
getting
10
people
into
substance
use
disorder
treatment,
with
one
study
11
finding
that
users
of
syringe
services
programs
are
five
12
times
more
likely
to
enter
treatment
than
those
who
did
not
13
participate.
14
8.
The
national
academies
of
sciences,
engineering,
and
15
medicine
recommends
that
states
expand
access
to
syringe
16
services
programs
combined
with
opioid
agonist
therapies
in
17
accessible
venues.
>
18
______________________________
ISENHART
of
Dubuque
-2-
H8118.3694
(3)
88
ss/rh
2/
2